High-flux Hemodialysis Versus Hemodiafiltration for End-Stage Renal Disease
Launched by GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL · Mar 5, 2018
Trial Information
Current as of August 15, 2025
Unknown status
Keywords
ClinConnect Summary
Hemodialysis using diffusion, ultrafiltration and convection principle to remove harmful substances in the blood and excessive water, is one of the most commonly replacement therapy.
Hemodiafiltration is a combination of hemodialysis and hemofiltration with two modes of treatment advantages, both by diffusion and convection principle to remove harmful substances in the blood.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Subject has end-stage renal disease.
- • 2. Subject has been on regular dialysis treatment for at least 6 months.
- • 3. Subject has autologous vascular access.
- • 4. Subject is offered thrice weekly hemodialysis.
- • 5. Subject is offered 4 hours duration hemodialysis.
- Exclusion Criteria:
- • 1. Infectious disease
- • 2. Poor echocardiographic window that was unsuitable for interpretation
About Guangdong Provincial People's Hospital
Guangdong Provincial People's Hospital is a leading tertiary healthcare institution located in Guangdong Province, China, renowned for its comprehensive medical services and advanced research capabilities. As a prominent clinical trial sponsor, the hospital is dedicated to advancing medical science through innovative research and the rigorous evaluation of new therapies and interventions. With a multidisciplinary team of experienced clinicians and researchers, the institution prioritizes patient safety and ethical standards while fostering collaborations with academic and industry partners to enhance healthcare outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, Guangdong, China
Guangzhou, , China
Patients applied
Trial Officials
Wei Shi, MD,PhD
Principal Investigator
Guangdong Provincial People's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials